Prevalence of C-cell hyperplasia in patients with normal basal and pentagastrin-stimulated calcitonin

Thyroid

Volumn 10, Issue 5, 2000, Pages 413-416

  Scheuba, Chr ^a   Kaserer, K ^a   Kotzmann, H ^a   Bieglmayer, Chr ^a   Niederle, B ^a   Vierhapper, H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; PENTAGASTRIN;

ARTICLE; AUTOPSY; CELL HYPERPLASIA; FEMALE; HISTOLOGY; HUMAN; HYPERTHYROIDISM; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; THYROID PARAFOLLICULAR CELL; THYROIDECTOMY;

EID: 0033918210     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.413     Document Type: Article

References (22)

1. Guyetant S, Rousselet MC, Durigon M, Chappard D, Franc B, Guerin O, Saint-Andre JP 1997 Sex-related C cell hyperplasia in the normal human thyroid: A quantitative autopsy study [see comments]. J Clin Endocrinol Metab 82:42-47.
2. Santeusanio G, Iafrate E, Partenzi A, Mauriello A, Autelitano F, Spagnoli L 1997 A critical reassessment of the concept of C-cell hyperplasia of the thyroid. Appl Immunohistochem 5:160-172.
3. Gibson WG, Peng TC, Croker BP 1982 Age-associated C-cell hyperplasia in the human thyroid. Am J Pathol 106:388-393.
4. Kotzmann H, Schmidt A, Scheuba C, Kaserer K, Watschinger B, Söregi G, Niederle B, Vierhapper H 1999 Basal calcitonin levels and the response to pentagastrin stimulation in patients after kidney transplantation or on chronic hemodialysis an indicators of medullary carcinoma. Thyroid 9:943-947.
5. Perry A, Molberg K, Albores-Saavedra J. 1996 Physiologic versus neoplastic C-cell hyperplasia of the thyroid: Separation of distinct histologic and biologic entities. Cancer 77:750-756.
6. LiVolsi, VA 1997 C cell hyperplasia/neoplasia [editorial; comment], J Clin Endocrinol Metab. 82:39-41.
7. Vierhapper H, Raber W, Bieglmayer C, Kaserer K, Weinhäusl A, Niederle B. 1997 Routine measurement of plasma calcitonin in nodular thyroid diseases. J Clin Endocrinol Metab 82:1589-1593.
8. McDermott MB, Swanson PE, Wick MR 1995 Immunostains for collagen type IV discriminate between C-cell hyperplasia and microscopic medullary carcinoma in multiple endocrine neoplasia, type 2a. Hum Pathol 26:1308-1312.
9. Rosai J, Carangiu M, DeLellis RA 1992 Atlas of Tumor Pathology: Tumors of the Thyroid Gland, 3dr series. Armed Forces Institute of Pathology; Washington DC: pp 247-258.
10. Kaserer K, Scheuba C, Neuhold N, Weinhäusl A, Vierhapper H, Haas OA, Niederle B 1998 C-cell hyperplasia and medullary thyroid carcinoma in patients routinely screened for serum calcitonin. Am J Surg Pathol 22:722-728.
11. DeLellis RA, Nunnemacher G, Wolfe HJ 1977 C-cell hyperplasia. An ultrastructural analysis. Lab Invest 36:237-248.
12. Fink M, Weinhäusl A, Niederle B, Haas OA 1996 Distinction between sporadic and hereditary medullary thyroid carcinoma (MTC) by mutation analysis of the RET proto-oncogene. Study Group Multiple Endocrine Neoplasia Austria (SMENA). Int J Cancer 69:312-316.
13. Carney JA, Sizemore GW, Hayles AB 1978 Multiple endocrine neoplasia, type 2b. Pathobiol Annu 8:105-153.
14. Mathew CG, Chin KS, Easton DF, Thorpe K, Carter C, Liou GI, Fong SL, Bridges CD, Haak H, Kruseman AC, et al 1987 A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 328:527-528.
15. Simpson NE, Kidd KK, Goodfellow PJ, McDermid H, Myers S, Kidd JR, Jackson CE, Duncan AM, Farrer LA, Brasch K, et al 1987 Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature 328:528-530.
16. Norum RA, Lafreniere RG, O'Neal LW, Nikolai TF, Delaney JP, Sisson JC, Sobol H, Lenoir GM, Ponder BA, Willard HF, et al 1990 Linkage of the multiple endocrine neoplasia type 2B gene (MEN2B) to chromosome 10 markers linked to MEN2A. Genomics 8:313-317.
17. Pacini F, Fontanelli M, Fugazzola L, Elisei R, Romei C, Di Coscio G, Miccoli P, Pinchera A 1994 Routine measurement of serum calcitonin in nodular thyroid diseases allows the preoperative diagnosis of unsuspected sporadic medullary thyroid carcinoma [see comments]. J Clin Endocrinol Metab 78:826-829.
18. Rieu M, Lame MC, Richard A, Lissak B, Sambort B, Vuong-Ngoc P, Berrod JL, Fombeur JP 1995 Prevalence of sporadic medullary thyroid carcinoma: the importance of routine measurement of serum calcitonin in the diagnostic evaluation of thyroid nodules [see comments]. Clin Endocrinol (Oxf) 42:453-460.
19. Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas O, Niederle B 1999 Is medullary thyroid cancer predictable. Surgery 126:1089-1095.
20. Libbey NP, Nowakowski KJ, Tucci JR 1989 C-cell hyperplasia of the thyroid in a patient with goitrous hypothyroidism and Hashimoto's thyroiditis [see comments]. Am J Surg Pathol 13:71-77.
21. Inoue S, Yokoyama S, Nakayama I, Noguchi S 1990 An immunohistochemical study of calcitonin-containing cells in benign and malignant thyroid lesions. Acta Pathol Jpn 40:187-192.
22. Fukao A, Takamatsu J, Shimamoto C, Kuma K, Ohsawa N 1998 Persistently increased gastrin and decreased pepsinogen concentrations in serum from some patients with Graves' disease of triiodothyronine-predominant type and common type. Thyroid 8:259-263.